Emerging treatments in lung cancer - targeting the RLIP76 molecular transporter [0.03%]
肺癌的新疗法-作用于分子转运体RLIP76
Lawrence E Goldfinger,Seunghyung Lee
Lawrence E Goldfinger
Multidrug resistance in lung cancer cells is a significant obstacle in the treatment of lung cancer. Resistance to chemotherapeutic agents is often the result of efflux of the drugs from cancer cells, mediated by adenosine triphosphate (ATP...